GAM Holding’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-12,568
Closed -$1.23M 253
2022
Q2
$1.23M Hold
12,568
0.08% 175
2022
Q1
$1.18M Hold
12,568
0.06% 190
2021
Q4
$1.07M Hold
12,568
0.05% 195
2021
Q3
$1.21M Sell
12,568
-3,013
-19% -$285K 0.06% 196
2021
Q2
$1.52M Sell
15,581
-4,123
-21% -$395K 0.07% 202
2021
Q1
$1.92M Buy
+19,704
New +$2.07M 0.09% 204
2020
Q4
Sell
-84,618
Closed -$8.14M 309
2020
Q3
$8.14M Buy
84,618
+11
+0% +$1.27K 0.49% 55
2020
Q2
$10.3M Sell
84,607
-7
-0% -$774 0.64% 36
2020
Q1
$7.32M Sell
84,614
-3,896
-4% -$381K 0.5% 53
2019
Q4
$9.51M Buy
88,510
+3
+0% +$314 0.45% 57
2019
Q3
$7.97M Hold
88,507
0.35% 75
2019
Q2
$7.47M Buy
88,507
+8,100
+10% +$665K 0.29% 88
2019
Q1
$7.08M Buy
80,407
+28,007
+53% +$2.34M 0.3% 87
2018
Q4
$3.74M Sell
52,400
-6,300
-11% -$604K 0.19% 132
2018
Q3
$7.22M Sell
58,700
-51,600
-47% -$5.85M 0.26% 105
2018
Q2
$10.8M Hold
110,300
0.38% 71
2018
Q1
$9.15M Sell
110,300
-8,900
-7% -$752K 0.32% 79
2017
Q4
$9.25M Hold
119,200
0.28% 90
2017
Q3
$7.3M Hold
119,200
0.31% 93
2017
Q2
$5.48M Buy
119,200
+4,300
+4% +$209K 0.08% 298
2017
Q1
$4.97M Buy
114,900
+8,400
+8% +$360K 0.08% 308
2016
Q4
$4.12M Buy
+106,500
New +$4.82M 0.07% 310
2016
Q3
Sell
-44,000
Closed -$2M 964
2016
Q2
$2M Sell
44,000
-15,300
-26% -$704K 0.03% 521
2016
Q1
$2.35M Buy
59,300
+9,600
+19% +$381K 0.04% 441
2015
Q4
$2.81M Buy
+49,700
New +$2.53M 0.04% 410
2015
Q1
Sell
-100,000
Closed -$2.23M 1122
2014
Q4
$2.23M Buy
100,000
+63,000
+170% +$1.19M 0.03% 478
2014
Q3
$580K Hold
37,000
0.01% 815
2014
Q2
$549K Hold
37,000
0.01% 815
2014
Q1
$596K Hold
37,000
0.01% 791
2013
Q4
$346K Buy
37,000
+10,000
+37% +$97.6K 0.01% 731
2013
Q3
$306K Buy
27,000
+19,000
+238% +$261K 0.01% 883
2013
Q2
$107K Buy
+8,000
New +$98.3K ﹤0.01% 822

Other funds holding NBIX